Skip to main content
. 2018 Nov 16;9(90):36202–36219. doi: 10.18632/oncotarget.26329

Table 2. GI50 of CDNB, 2HF and 2HF in presence of CDNB on H358 lung cancer cells.

H358 NSCLC
Substrate GI50 (μM)
CDNB 2.83 ± 0.148
2HF 25.44 ± 0.671
2HF in presence of 1 μM CDNB 8.25 ± 0.786